Dear Editor,
Members of Foxa transcription factor family, namely Foxa1, Foxa2, and Foxa3, play crucial roles in guiding hepatic differentiation and hepatic homeostatic maintenance (Le Lay and Kaestner, 2010; Zaret and Carroll, 2011) . They act at several critical time points to regulate hepatic differentiation as early as embryonic definitive endoderm (DE) stage (Gualdi et al., 1996) . Combination of both Foxa1 and Foxa2 were required for formation of foregut DE cells and the further liver bud differentiation during embryonic hepatic development (Lee et al., 2005) . Foxa proteins can bind the condensed chromatin of Alb1 enhancer and induce local chromatin relaxation prior to the initiation of transcription (Cirillo et al., 2002) . The binding of Foxa on Alb1 enhancer before transcription activation determined the developmental competence by pre-marking the chromatin. Thus, Foxa proteins were proposed to behave as pioneer factors in DE to prime hepatic genes prior to their actual transcription activation in nascent liver (Zaret and Carroll, 2011) .
Although Foxa2 binding profiles were extensively mapped in adult liver cells using ChIP-sequencing (ChIP-seq) technology (Hoffman et al., 2010; Tuteja et al., 2009; Wallerman et al., 2009; Wederell et al., 2008) , binding profile of Foxa proteins at embryonic DE stage has not been obtained yet. Functions of Foxa family have been known with significant differences between embryonic hepatic developing stage and post-developing stage (Cirillo et al., 2002; Li et al., 2011 Figure S1) .
The obtained DE cells were used to map Foxa2 binding sites by ChIP-seq. We obtained 4.2 million reads, and 36675 peaks were generated by Model-based Analysis of ChIP-seq (MACS) program after aligning these reads to the mouse genome and retrieving only the unique reads ( Figure 1A ) (Zhang et al., 2008) . To verify the peaks, ChIP-qPCR assays were performed. 28 out of 30 randomly selected peak sites were positive for Foxa2 binding, while all 21 randomly selected non-peak sites were negative (Supplementary Figure S2A Table S1 ) (Kim and Volsky, 2005) . Our results indicated that activation of many Foxa2 target genes indeed happened later than the Foxa2 binding and revealed a widely existing uncoupling between promoter/enhancer occupation and immediate transcription activation during the process of hepatic differentiation, consistent with previous observations made on Alb1 gene activation (Gualdi et al., 1996) . Previously, Foxa binding was suggested to correlate with histone H3 lysine 4 dimethylation (H3K4me2) in human cancer cell lines (Lupien et al., 2008) . In order to investigate whether the binding of Foxa2 at DE stage could also be related to certain histone modifications, we assessed the histone modification status on Foxa2 target genes in DE cells. Genes such as Afp, Ttr, and 9 other genes, whose promoter/enhancers were occupied by Foxa2 at DE stage, and transcription activation occurred at early hepatic cell stage, were categorized as "late genes" (Supplementary Figure S3A and C); Genes whose expression levels were concomitantly up-regulated with Foxa2 binding at DE stage, such as Foxa2, Gata4 and 9 other genes, were grouped as "early genes" (Supplementary Figure S3B and D) . Histone H3 acetylation (H3ac) status on all of these genes in DE cells was first examined. H3ac around Foxa2 binding sites could only be detected on the "early genes", but not on the "late genes"
(Supplementary Figure S4A) . Next, histone H3 methylation status on these genes was examined. High levels of both H3K4me2 and H3K27me3 were detected on the "late genes" around Foxa2 recognition sites ( Figure 1C) . In ES cells, where Foxa2 was not expressed, only repressive H3K27me3 modification, but not H3K4me2, was detected on "late genes" (Supplementary Figure S5) . In contrast, both H3K4me2 and H3K27me3 were present on "early genes" in ES cells (Supplementary Figure S5) . Sequential-ChIP assay results suggested that H3K4me2, H3K27me3 and Foxa2 binding occurred on the same promoter/enhancer, but not from several distinct cell populations (Supplementary Figure S6) . Next, we generated Foxa2 knock-down (Foxa2-KD) ES cells and induced these cells to differentiate into DE cells. Foxa2-KD resulted in significantly reduced levels of H3K4me2, but not H3K27me3, only on "late genes" (Figure 1D and E). On "early genes", no consistent pattern of H3K4me2 changes could be found upon Foxa2-KD ( Figure 1D ). H3K27me3 levels were significantly increased in Foxa2-KD cells ( Figure   6 1E), and H3ac levels were not changed upon Foxa2-KD (Supplementary Figure S4B) . Statistical analysis from 11 "late genes" and 11 "early genes" showed a significant reduction of H3K4me2 levels on "late genes" upon Foxa2-KD, but not on "early genes" ( Figure 1F ). These results suggested that knocking-down Foxa2 specifically affected H3K4me2 levels on "late genes" during hepatic specification. Taken The same ChIP assays in D were performed on 11 late genes and 11 early genes. The results were summarized in box plots. Whiskers corresponded to the largest and smallest observations. The bottom and top of the box and the middle line corresponded to lower quartile, upper quartile and median, respectively. *P < 0.05, **P < 0.01 in C-F.
(G) A schematic model indicating functions of Foxa2 in hepatic differentiation.
